science wire

« BACK

Pharmacology



Results 251 - 300 of 3009.


Pharmacology - Health - 16.12.2021
Needs of patients with opioid use disorder similar to other patients
With the magnitude of the opioid crisis, there has been a growing call for treatment of patients with opioid use disorder to be expanded beyond specialist care and into the hands of primary care physicians. Yet while primary care providers are positioned to offer these services - and are already allowed to prescribe buprenorphine and naloxone treatment - many choose not to, citing a lack of institutional support and discomfort managing the more complex medical needs sometimes associated with this disorder.

Pharmacology - Health - 15.12.2021
TaBriX, University and TB Alliance to develop drug-resistant tuberculosis treatments
TaBriX, University and TB Alliance to develop drug-resistant tuberculosis treatments
TaBriX is a new spin-out company from The University of Manchester (UoM) with the mission to create novel anti-virulence drugs to fight difficult-to-treat infections.

Pharmacology - 15.12.2021
Childhood trauma linked to psychotic symptoms in young cannabis users
Childhood trauma may increase the chance of young people experiencing psychotic symptoms when using cannabis, University of Queensland research has found.

Pharmacology - Social Sciences - 15.12.2021
Teen use of illicit drugs decreased in 2021, as the COVID-19 pandemic continued
Declines in adolescent use of illicit drugs reported in 2021 were the largest and most sweeping ever recorded in the past 46 years, according to the Monitoring the Future study.

Health - Pharmacology - 14.12.2021
Q and A with the experts: COVID-19 variants
Many people will need a third dose of the vaccine to protect against Omicron. Omicron is the latest COVID-19 variant of concern, and it is expected to change the course of the pandemic.

Health - Pharmacology - 14.12.2021
A medication against SARS-CoV-2
Vaccines against the SARS-CoV-2 virus have been made possible by an unprecedented worldwide partnership. But mediacations against Covid-19 have as yet seen only partial success. With the support of the Bavarian Research Foundation, a Munich research team has developed a protein which has reliably prevented infection by the virus and its variants in cell tests.

Pharmacology - Health - 14.12.2021
Opinion: The richest countries are vaccine hoarders. Try them in international court
Opinion: The richest countries are vaccine hoarders. Try them in international court
Millions have died unnecessarily of Covid and millions more will in 2022 unless something changes. Justice must be done says Professor Anthony Costello (UCL Institute for Global Health).

Health - Pharmacology - 10.12.2021
RECOVERY Trial launches in South Africa
The world's largest clinical trial investigating treatments for COVID-19 has now launched in South Africa, with the first patient recruited today.

Health - Pharmacology - 09.12.2021
The long-term effects of sepsis: years of treatment and care needs
The long-term effects of sepsis: years of treatment and care needs
Three in four sepsis survivors experience new-onset memory problems, psychological impairments or physical diagnoses. This also applies to more than half of sepsis survivors under the age of 40 at the time of their discharge from hospital. These are just two of the findings of a retrospective analysis of anonymized health claims data conducted by a team of researchers from Jena University Hospital, Charité - Universitätsmedizin Berlin and the Research Institute of the Local Health Care Funds (AOK).

Health - Pharmacology - 09.12.2021
Two-year follow up shows delaying umbilical cord clamping saves babies' lives
Two-year follow up shows delaying umbilical cord clamping saves babies’ lives
An Australian-led study finds that aiming to wait just 60 seconds to clamp the umbilical cord of very premature babies at birth continues to have benefits two years on - decreasing the child's risk of death or major disability.

Health - Pharmacology - 09.12.2021
Important message for students about new COVID-19 safety guidance
Important message for students about new COVID-19 safety guidance
An update following the Prime Minister's announcement on 8 December of new Plan B safety measures. Please read this message carefully as it includes important information about what these changes mean for you.

Health - Pharmacology - 09.12.2021
How SARS-Cov-2 is changed by antiviral treatments focus of new UCL study
How SARS-Cov-2 is changed by antiviral treatments focus of new UCL study
Scientists at UCL will sequence the DNA of more than 10,000 samples of the SARS-CoV-2 virus to see if or how its genome is changed by different antiviral Covid-19 treatments.

Health - Pharmacology - 09.12.2021
First UK trial to assess use of antivirals to treat COVID-19 set to be begin
The first clinical trial in the UK to investigate whether antiviral drugs could help reduce the severity of COVID-19 is due to start.

Health - Pharmacology - 08.12.2021
Rapid therapeutic approaches against viral diseases
Rapid therapeutic approaches against viral diseases
Research team with new development pipeline for RNA-based drugs successful in Europe-wide competition 08. Viruses are a major problem for human health worldwide - and not just since the outbreak of the SARS-CoV2 pandemic. Despite successful vaccine development, there are still no effective drugs for most viral diseases.

Health - Pharmacology - 03.12.2021
The pandemic affects public health with a 31% drop in new diagnoses and a fall of 47% in face-to-face visits to primary healthcare centres
Two studies led by CRES-UPF researchers, which compare data for 2019 (without the pandemic) and 2020 (with the pandemic) in the field of the public primary healthcare system in Catalonia, reveal major effects on the health of the population and changes in the care model.

Pharmacology - Life Sciences - 02.12.2021
Innovative research into new vaccines
Innovative research into new vaccines
Projects taking part in the National Research Programme "Covid-19" (NRP 78) of the Swiss National Science Foundation (SNSF) are pursuing highly promising approaches in a drive to develop new vaccines.

Health - Pharmacology - 30.11.2021
Understanding omicron, the new COVID-19 variant
Countries around the world are making preparations against omicron, a new variant of the novel coronavirus that causes COVID-19.

Pharmacology - Health - 29.11.2021

Health - Pharmacology - 29.11.2021
Collaboration could enable cancer patients to get faster and more personalised treatment | University of Cambridge
Collaboration could enable cancer patients to get faster and more personalised treatment | University of Cambridge
GE Healthcare, the and Cambridge University Hospitals have agreed to collaborate on developing an application aiming to improve cancer care, with Cambridge providing clinical expertise and data to sup

Pharmacology - Health - 25.11.2021

Health - Pharmacology - 24.11.2021
Research shapes new miscarriage guidelines
Research led by the University of Birmingham has helped to shape guidelines which could mean thousands of women with prior miscarriage, and bleeding in early pregnancy, could be eligible for treatment with progesterone each year. The updated guidance, announced today by the National Institute for Health and Care Excellence (NICE), follows a review of evidence by NICE's independent guideline committee.

Health - Pharmacology - 23.11.2021
Antibody treatment for Covid-19
Antibody treatment for Covid-19
More than 80 percent efficacy in prevention of serious illness through Covid-19 A new treatment could prevent serious illness in case of Covid-19 infections during the pandemic.

Health - Pharmacology - 23.11.2021
End-stage kidney disease patients show increased risk of infection, mortality from COVID-19
Patients undergoing long-term dialysis, especially Black and Hispanic patients and those living in nursing homes, were severely impacted by the COVID-19 pandemic, according to a nationwide study by University of Michigan researchers. The study , published on JAMA Network Open, examined nearly the entire Medicare dialysis population-almost 500,000 patients-in the United States across the entire year of 2020.

Health - Pharmacology - 22.11.2021
Q and A with the Experts: Long COVID
Dr. Tejal Patel discusses the symptoms that persist in people with long COVID and how they can be treated. Long COVID symptoms are believed to affect about 10 per cent of those infected and can last from weeks to months. What symptoms persist in people with long COVID, and how can these be treated? Dr. Tejal Patel , a pharmacy professor at the University of Waterloo, provides answers to these and other questions.

Research Management - Pharmacology - 22.11.2021
Researchers named in global top one per cent of Clarivate Highly Cited Researchers
Nineteen Monash academics have been named among the world's most influential researchers in their fields as part of Clarivate's 2021 list of Highly Cited Researchers.

Health - Pharmacology - 19.11.2021
First gene therapy approach for MLC leukoencephalopathy designated as orphan drug
First gene therapy approach for MLC leukoencephalopathy designated as orphan drug
The European Medicines Agency (EMA) has designated as an orphan drug the first gene therapy approach to treat megalencephalic leukoencephalopathy with subcortical cysts (MLC), an ultra-rare disease that appears in childhood and leads to various neurological complications.

Health - Pharmacology - 18.11.2021
Pregnant, Breastfeeding or Trying? Here’s What COVID-19 Means for You
As the U.S. continues to see low vaccination rates in pregnant people, experts at UC San Diego Health weigh in on the latest research With holidays and winter weather approaching, concerns about COVID-19 infections are on the rise.

Health - Pharmacology - 18.11.2021